Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul;35(7):1482-4.
doi: 10.2337/dc11-2420. Epub 2012 May 18.

Insights into the pathogenicity of rare missense GCK variants from the identification and functional characterization of compound heterozygous and double mutations inherited in cis

Affiliations

Insights into the pathogenicity of rare missense GCK variants from the identification and functional characterization of compound heterozygous and double mutations inherited in cis

Nicola L Beer et al. Diabetes Care. 2012 Jul.

Abstract

Objective: To demonstrate the importance of using a combined genetic and functional approach to correctly interpret a genetic test for monogenic diabetes.

Research design and methods: We identified three probands with a phenotype consistent with maturity-onset diabetes of the young (MODY) subtype GCK-MODY, in whom two potential pathogenic mutations were identified: [R43H/G68D], [E248 K/I225M], or [G261R/D217N]. Allele-specific PCR and cosegregation were used to determine phase. Single and double mutations were kinetically characterized.

Results: The mutations occurred in cis (double mutants) in two probands and in trans in one proband. Functional studies of all double mutants revealed inactivating kinetics. The previously reported GCK-MODY mutations R43H and G68D were inherited from an affected father and unaffected mother, respectively. Both our functional and genetic studies support R43H as the cause of GCK-MODY and G68D as a neutral rare variant.

Conclusions: These data highlight the need for family/functional studies, even for previously reported pathogenic mutations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pedigrees for the three probands. Squares and circles denote males and females, respectively. Filled symbols represent hyperglycemic individuals, and open symbols correspond to those with normoglycemia. Fasting plasma glucose values and mutation status for each family member are given underneath the appropriate symbol. An arrow indicates the proband in each family. N, no mutation; N/A, data not available.

References

    1. Odem J, Munzinger E, Violand S, Van Morlan A, Rife D, Bachrach B. An infant with combination gene mutations for monogenic diabetes of youth (MODY) 2 and 4, presenting with diabetes mellitus requiring insulin (DMRI) at 8 months of age. Pediatr Diabetes 2009;10:550–553 - PubMed
    1. Loomba-Albrecht LA, Jame M, Bremer AA. A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2. Diabetes Res Clin Pract 2010;87:e23–e25 - PubMed
    1. Rubio-Cabezas O. Diagnosing monogenic diabetes: common misinterpretations of genetic findings. Pediatr Diabetes 2009;10:497–499 - PubMed
    1. Osbak KK, Colclough K, Saint-Martin C, et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 2009;30:1512–1526 - PubMed
    1. Davis EA, Cuesta-Muñoz A, Raoul M, et al. Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis. Diabetologia 1999;42:1175–1186 - PubMed

Publication types